Table 2. Investigational drugs targeting... | Rockefeller University Press

Table 2.

Investigational drugs targeting IL-17 in indications of interest

INN/Code	Target	Construct	Indication^a
Bimekizumab	IL-17A/F	Humanized mAb	Pso, PsA, AS
M1095	IL-17A/F	Nanobody	Pso, PsA
ALX-0761	IL-17A/F	Nanobody	Pso, PsA
BCD-085	IL-17A	mAb	Pso, PsA
COVA322	IL-17A/TNF	Bispecific mAb	Pso, PsA

INN/Code	Target	Construct	Indicationa
Bimekizumab	IL-17A/F	Humanized mAb	Pso, PsA, AS
M1095	IL-17A/F	Nanobody	Pso, PsA
ALX-0761	IL-17A/F	Nanobody	Pso, PsA
BCD-085	IL-17A	mAb	Pso, PsA
COVA322	IL-17A/TNF	Bispecific mAb	Pso, PsA

INN, international nonproprietary names; Pso, psoriasis.

In clinical trials/planned.

Sharing Unavailable